Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2023 15:07 ET | Source: Robbins LLP

IBRX Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in the ImmunityBio, Inc. Class Action

SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
July 24, 2023 17:49 ET | Source: Portnoy Law

ImmunityBio investors:Please contact the Portnoy Law Firm to recover your losses; August 29, 2023 deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ImmunityBio, Inc....
July 18, 2023 18:31 ET | Source: Robbins LLP

IBRX Stock News: Contact Robbins LLP for Information Regarding ImmunityBio, Inc. Class Action

SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
July 13, 2023 17:40 ET | Source: Robbins LLP

ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action

SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
July 05, 2023 12:19 ET | Source: Robbins LLP

ImmunityBio, Inc. (IBRX) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against ImmunityBio, Inc.

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
May 11, 2023 19:56 ET | Source: Kaplan Fox & Kilsheimer LLP

IMMUNITYBIO: Kaplan Fox Investigates ImmunityBio

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ImmunityBio, Inc. (“ImmunityBio” or the “Company”)...